Go beyond skin inflammation with a full blood panel
Includes inflammation, hormone, and metabolic markers in a single draw.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
At a glance
- CBD, or cannabidiol, is a non-psychoactive compound from the cannabis and hemp plant, used topically for its anti-inflammatory and antioxidant effects.
- CBD is not the same as hemp seed oil, which is pressed from seeds and contains little to no cannabidiol.
- CBD is a good fit for inflamed, redness-prone, or reactive skin, and has been studied in acne, eczema, and rosacea.
- CBD may help with inflammation, redness, and UV-related oxidative damage.
- Evidence strength: Emerging, with early human trials but variable product quality and regulation.
What is CBD (cannabidiol)?
CBD, short for cannabidiol, is a non-psychoactive phytocannabinoid extracted from Cannabis sativa, including hemp varieties. An important distinction: CBD is not the same as hemp seed oil. Hemp seed oil is pressed from the plant's seeds and contains little to no cannabidiol, while CBD is extracted from the flowers and leaves. CBD interacts with the skin's endocannabinoid system, which helps regulate inflammation and oil production. Because the market is loosely regulated, the amount of CBD listed on a label is not always accurate, so product quality varies widely.
What skin type is CBD (cannabidiol) best for?
CBD is best suited to inflamed, redness-prone, acne-prone, and sensitive skin. Its calming profile makes it most useful for people dealing with irritation or inflammatory conditions, rather than as a general anti-aging active. Most skin types tolerate well-made topical CBD.
What does CBD help with?
CBD is studied across several inflammatory skin concerns. A review of CBD and acne describes reduced sebum-related inflammation and lower levels of inflammatory signals. A randomized trial in atopic dermatitis found that a CBD formulation improved disease severity scores over two weeks. In a rosacea model, CBD reduced redness and inflammation. For sun-related damage, a pilot clinical trial of a nano-CBD cream found it lowered UV-A-induced DNA damage in human skin.
How do you know if CBD can help your skin?
CBD is worth considering if you have inflammatory redness, acne, or eczema flares and want to try a calming topical. Choose products that provide third-party testing or a certificate of analysis so you know how much CBD they actually contain. Topical CBD appears well tolerated: a tolerability study found no irritation or sensitization on healthy skin. Patch test before adding it to your routine.
How do you use CBD?
CBD is typically applied after cleansing in a serum, cream, or balm, once or twice a day, and it layers under sunscreen in the morning. Follow the directions on the specific product, since concentrations vary a lot between brands. For targeted calming, you can apply it to areas that tend to flare. Expect gradual reduction in redness and irritation over a few weeks rather than an immediate change, and choose a product with third-party testing so you know what you are actually applying.
What should you use with CBD?
CBD layers well with soothing hydrators, ceramides, and niacinamide, and it fits comfortably under daily sunscreen. It can be paired with retinoids or acids to help calm the irritation those actives sometimes cause. There are no widely reported conflicts, so the main consideration is product quality rather than ingredient pairing.
Evidence strength
Emerging: Early human trials for acne, eczema, and UV protection are promising, and topical CBD looks safe in the short term. The main limits are small study sizes and the wide variation in product quality and regulation, which makes results hard to generalize. Real-world results depend heavily on the specific product and its verified cannabidiol content.
References
- Peyravian N, Deo S, Daunert S, Jimenez JJ. The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne. Journal of Inflammation Research. 2022;Volume 15:2795-2801. doi:10.2147/JIR.S355489
- Gao Y, Li Y, Tan Y, et al. Novel cannabidiol aspartame combination treatment (JW‐100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double‐blinded placebo‐controlled interventional study. Journal of Cosmetic Dermatology. 2022;21(4):1647-1650. doi:10.1111/jocd.14263
- Shrestha C, Yoo EH, Deshar B, et al. Cannabidiol as a therapeutic agent for rosacea through simultaneous inhibition of multiple inflammatory pathways. BMB Reports. 2025;58(8):357-363. doi:10.5483/BMBRep.2024-0115
- McCormick E, Han H, Abdel Azim S, et al. Topical nanoencapsulated cannabidiol cream as an innovative strategy combating UV-A–induced nuclear and mitochondrial DNA injury: A pilot randomized clinical study. Journal of the American Academy of Dermatology. 2024;91(5):855-862. doi:10.1016/j.jaad.2024.06.088
- Maghfour J, Rietcheck H, Szeto MD, et al. Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single‐centre randomized evaluator‐blinded clinical and in vitro studies in normal skin. Clinical and Experimental Dermatology. 2021;46(8):1518-1529. doi:10.1111/ced.14749















